Cadence, a provider of vertically integrated contract manufacturing solutions to the medtech and pharma industries, has appointed Pat McCarty as its new chief financial officer (CFO), effective immediately.

McCarty’s background includes senior financial roles at global medical device manufacturing companies like Paragon Medical and Merit Medical. He has a track record of driving strategic transformation in both public and private equity-backed manufacturing organizations.

Throughout his career, McCarty led initiatives to boost forecasting, procurement, pricing, and manufacturing efficiency. He’s built scalable financial infrastructure and improved operational performance with a disciplined and strategic approach to financial management.

Cadence said his leadership will be instrumental as the company continues to expand its capabilities and footprint.

“We are excited to welcome Pat to the Cadence leadership team,” said Cadence president and CEO Rob Werge. “His expertise aligns well with our strategic direction, and we look forward to the impact he will make as we continue to grow and innovate.”

McCarty succeeds Ken Cleveland, who has retired after a 29-year tenure with the company. Cadence thanked him for outstanding contributions over nearly three decades, as he was key in the company’s financial growth and long-term stability.

In December, the company revealed its membership in the Medical Devices Cluster in Costa Rica, becoming the 64th member of this initiative. The cluster promotes collaboration among medical device companies operating in Costa Rica, allowing synergy and co-creation within the industry.